3/18
07:00 am
xrtx
XORTX Announces Substitute Director Nominees for its Upcoming Annual and Special Meeting of Shareholders
Medium
Report
XORTX Announces Substitute Director Nominees for its Upcoming Annual and Special Meeting of Shareholders
3/13
07:16 am
xrtx
XORTX Reports that Independent Proxy Advisory Firms Recommend XORTX Shareholders Vote “For” the Share Consolidation [Yahoo! Finance]
High
Report
XORTX Reports that Independent Proxy Advisory Firms Recommend XORTX Shareholders Vote “For” the Share Consolidation [Yahoo! Finance]
3/13
07:00 am
xrtx
XORTX Reports that Independent Proxy Advisory Firms Recommend XORTX Shareholders Vote “For” the Share Consolidation
High
Report
XORTX Reports that Independent Proxy Advisory Firms Recommend XORTX Shareholders Vote “For” the Share Consolidation
3/5
07:00 am
xrtx
XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders
Medium
Report
XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders
2/4
06:00 pm
xrtx
XORTX Provides Update on Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems
High
Report
XORTX Provides Update on Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems
1/2
07:41 am
xrtx
XORTX Therapeutics Says Published Research Supports Company Approach to Gout Treatment [Yahoo! Finance]
Low
Report
XORTX Therapeutics Says Published Research Supports Company Approach to Gout Treatment [Yahoo! Finance]
12/31
07:28 pm
xrtx
XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update [Canadian Business Journal (Canada)]
Medium
Report
XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update [Canadian Business Journal (Canada)]
12/31
06:22 pm
xrtx
XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update [Yahoo! Finance]
Low
Report
XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update [Yahoo! Finance]
3/20
05:01 pm
xrtx
Form 20-F XORTX Therapeutics Inc. For: Dec 31
Neutral
Report
Form 20-F XORTX Therapeutics Inc. For: Dec 31
3/19
06:02 am
xrtx
Form 6-K XORTX Therapeutics Inc. For: Mar 18
Medium
Report
Form 6-K XORTX Therapeutics Inc. For: Mar 18
3/13
11:22 am
xrtx
Form 6-K XORTX Therapeutics Inc. For: Mar 13
Low
Report
Form 6-K XORTX Therapeutics Inc. For: Mar 13
3/5
07:00 am
xrtx
Form 6-K XORTX Therapeutics Inc. For: Mar 05
Medium
Report
Form 6-K XORTX Therapeutics Inc. For: Mar 05
3/3
10:08 am
xrtx
Form 6-K XORTX Therapeutics Inc. For: Mar 03
Low
Report
Form 6-K XORTX Therapeutics Inc. For: Mar 03
2/27
07:39 am
xrtx
Form 6-K XORTX Therapeutics Inc. For: Dec 31
Medium
Report
Form 6-K XORTX Therapeutics Inc. For: Dec 31
2/18
06:10 am
xrtx
Form EFFECT XORTX Therapeutics Inc.
High
Report
Form EFFECT XORTX Therapeutics Inc.
2/13
06:03 am
xrtx
Form F-1/A XORTX Therapeutics Inc.
Low
Report
Form F-1/A XORTX Therapeutics Inc.
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register